What Is Embryo Cryopreservation and How Does It Work?

Embryo cryopreservation is the process of cooling fertilized embryos to extremely low temperatures, typically around −196 °C in liquid nitrogen, so they can be stored indefinitely and used later for pregnancy. The technique has been a routine part of fertility treatment for decades, and the vast majority of IVF clinics worldwide now rely on it. What makes it work is a combination of specialized protective chemicals, precise temperature control, and a careful understanding of what happens to cells when water inside them turns to ice.

Why Freezing Cells Is Hard in the First Place

The fundamental problem with freezing any living cell is ice. When water inside a cell freezes, the expanding crystals can puncture membranes and destroy internal structures. At the same time, as ice forms in the fluid surrounding the cell, the remaining liquid becomes increasingly concentrated with salts and other dissolved substances. The cell responds by losing water to balance that concentration, which causes it to shrink. If cooling is too rapid, there is not enough time for water to leave the cell, and intracellular ice forms, which is usually lethal to the cell.¹ If cooling is too slow, the prolonged exposure to highly concentrated solutions can also cause damage. The entire art of embryo cryopreservation is navigating between these two hazards.

Two Approaches to Freezing

Over roughly four decades, two main techniques have been developed to get embryos safely through the danger zone: controlled-rate slow freezing and vitrification.² They solve the ice problem in fundamentally different ways.

Slow freezing uses a programmable machine to lower the temperature gradually, typically over about two hours. Embryos are placed in a solution containing low concentrations of cryoprotective agents, and the cooling rate is carefully controlled so that ice forms outside the cells while the cells dehydrate at a manageable pace. The idea is to let the embryo shed enough water that dangerous intracellular ice never gets a chance to form.

Vitrification takes the opposite approach. Instead of trying to manage ice formation, it eliminates ice altogether. The embryo is immersed in a much higher concentration of cryoprotectants and then plunged directly into liquid nitrogen. The cooling happens so fast that the solution transitions into a glass-like solid state without forming any ice crystals at all. The word “vitrification” comes from the Latin for glass.

How the Two Methods Compare

Vitrification has largely overtaken slow freezing in clinical practice, and the numbers explain why. A systematic review and meta-analysis found that the survival rate of cleavage-stage embryos was substantially higher after vitrification compared with slow freezing, and the same held true for blastocysts.³ A head-to-head clinical study put specific numbers on the gap: survival was about 97% for vitrified embryos versus 83% for slow-frozen ones, and the proportion of embryos retaining excellent morphology after warming was roughly 92% versus 56%. Clinical pregnancy rates in that study were about twice as high in the vitrification group.⁴

That said, slow freezing has not disappeared entirely. Some clinics still use it for certain situations, and the technique has a longer track record. But the shift toward vitrification is one of the clearest trends in reproductive medicine over the past fifteen years.

The Role of Cryoprotectants

Cryoprotectants are the chemicals that make the whole process possible. They work by replacing some of the water inside cells and by altering the freezing behavior of the surrounding solution. Common agents include propylene glycol, dimethyl sulfoxide (DMSO), glycerol, and ethylene glycol. Ethylene glycol has become popular for both slow freezing and vitrification because of its relatively small molecular size, which helps it move into cells quickly.⁵ Sugars like sucrose are often added to the solution as well. They do not enter the cell but help draw water out of it, reducing the volume of freezable liquid inside.

The concentration of cryoprotectants matters enormously and differs between methods. Slow freezing uses lower concentrations because the gradual temperature drop gives the chemicals time to work. Vitrification requires higher concentrations because everything happens so fast, and the solution needs to be viscous enough to turn glass-like rather than crystallizing. The trade-off is that high concentrations of cryoprotectants can themselves be toxic to cells, so the embryo’s exposure time is kept very short during vitrification, sometimes just seconds before plunging into liquid nitrogen.

When Embryos Get Frozen

Embryos can be frozen at different developmental stages, and the choice has practical consequences. The two most common points are the cleavage stage, around day 2 or 3 after fertilization when the embryo has roughly four to eight cells, and the blastocyst stage, around day 5 or 6, when it has developed into a more complex structure of over a hundred cells with a fluid-filled cavity.

Blastocyst freezing has gained ground for several reasons. A retrospective study found that pregnancy rates were significantly higher when blastocysts were transferred compared with cleavage-stage embryos.⁶ Blastocyst transfer has also been associated with a lower risk of ectopic pregnancy. One study found the ectopic pregnancy rate was about 1.9% for thawed day-3 embryos versus just 0.3% for thawed day-5 embryos.⁷

The main drawback of waiting until day 5 is that not all embryos make it that far in culture. Some patients end up with no blastocysts to freeze even though they had viable-looking embryos at day 3. For this reason, some clinics will freeze earlier-stage embryos in cases where few embryos are available, hedging against the risk of losing them all during extended culture.

How Long Can Embryos Stay Frozen

Once an embryo reaches −196 °C, biological processes effectively stop. There is no metabolism, no cell division, no aging in any meaningful sense. The theoretical storage limit is indefinite, and clinical data supports long-term use. A study tracking embryos stored for 12 to over 17 years found a survival rate of 74% after thawing, and a third of those that were cultured further developed into blastocysts.⁸ Babies have been born from embryos stored for well over two decades. The science suggests that the duration of storage itself does not degrade embryo quality, though the freezing technique used at the time of storage matters. Embryos frozen with older slow-freezing methods tend to fare slightly less well upon thawing than those vitrified, regardless of how long they were stored.

The practical limits are more often legal and financial than biological. Storage fees accumulate over time, and different countries impose different rules on how long embryos may be kept. In the UK, for example, the default legal storage period has historically been ten years, though extensions are possible. In many US states, there is no statutory time limit, and the decision rests with the patients and their clinic agreements.

Why Clinics Freeze All Embryos Instead of Transferring Fresh

You might wonder why embryos would be frozen at all when a patient is right there, ready for a transfer. In the early days of IVF, embryo freezing was mostly a backup plan for extra embryos that were not transferred. Today, many clinics deliberately freeze all embryos from a cycle and delay the transfer to a later date. This “freeze-all” approach has become widespread for several reasons.

The most straightforward one is safety. The hormonal stimulation used to retrieve eggs can sometimes cause ovarian hyperstimulation syndrome, a condition where the ovaries swell and fluid leaks into the abdomen. It can range from uncomfortable to dangerous. Freezing all embryos and skipping a fresh transfer eliminates the risk of pregnancy making that condition worse. For patients who respond strongly to stimulation medications, including those with polycystic ovary syndrome, freeze-all is clearly recommended.⁹ It is also the preferred approach when patients plan to have embryos genetically tested before transfer, since the testing takes time.

The freeze-all strategy also allows for more flexible preparation of the uterine lining, separating the two demanding phases of IVF (egg retrieval and embryo transfer) into distinct cycles.¹⁰ Some clinicians also consider a deferred transfer in cases where unexpected uterine abnormalities are discovered during stimulation, or when progesterone levels rise prematurely, which can impair implantation.

Preparing for a Frozen Embryo Transfer

Transferring a thawed embryo requires that the uterine lining be in the right condition to accept implantation. There are two broad approaches: using the patient’s own natural cycle or using hormone replacement to build the lining artificially.

In a natural cycle protocol, the clinic monitors the patient’s own hormonal shifts and times the transfer to coincide with ovulation. A modified natural cycle uses the same approach but adds a trigger injection to make the timing of ovulation more predictable. In a hormone replacement cycle, the patient takes estrogen to build the lining and then adds progesterone to prepare it for implantation, with no ovulation required.

Which approach produces better results has been debated. A network meta-analysis found that artificial hormone cycles ranked last among endometrial preparation methods, with lower live birth rates compared with natural cycle protocols. Women who conceived after artificial cycles also faced higher risks of pregnancy-induced high blood pressure, postpartum bleeding, and very preterm birth.¹¹ A Cochrane review, however, concluded that the evidence was insufficient to favor one protocol over another in women with regular cycles, reflecting how variable the study quality has been.¹² The general trend in recent research leans toward natural cycles when possible, but artificial cycles remain essential for patients who do not ovulate on their own.

Genetic Testing and Refreezing

Preimplantation genetic testing is increasingly common in IVF, and it intersects with cryopreservation in a couple of ways. The standard approach is to biopsy the embryo at the blastocyst stage, remove a few cells from the outer layer destined to become the placenta, and then freeze the embryo while the cells are sent for genetic analysis. Results usually take one to two weeks, and the embryo stays frozen in the meantime.

Some patients have embryos that were already frozen before genetic testing became available or before they decided they wanted it. In those cases, a “thaw, biopsy, and refreeze” strategy is used. The embryo is warmed, allowed to recover for at least an hour, biopsied, and then vitrified again.¹³ This double exposure to freezing understandably raises concerns, but studies have shown that high-quality blastocysts generally tolerate a second vitrification well. Survival rates after thawing do depend on embryo quality and the day of biopsy: excellent- and good-quality embryos survived at rates above 92%, while poor-quality embryos dropped to about 85%. Embryos biopsied on day 5 survived better than those biopsied on day 6.¹⁴

Health Outcomes for Children Born from Frozen Embryos

One of the most reassuring findings in reproductive medicine is that babies born from frozen embryo transfers generally do well. A large Finnish cohort study found that compared with fresh transfers, frozen embryo transfer babies had lower risks of preterm birth, low birthweight, and being small for gestational age. Singletons from frozen transfers weighed an average of 134 grams more at birth than those from fresh transfers.¹⁵

The picture is not entirely uncomplicated, though. That same tendency toward higher birthweight can overshoot: reviews have noted an increase in large-for-gestational-age babies after frozen transfer.¹⁶ And a large Scandinavian cohort study reported a modestly elevated risk of childhood cancer in children born after frozen embryo transfer, both compared with fresh transfers and with spontaneous conception. The absolute risk remained very low, on the order of about 19 per 100,000 person-years, but the relative increase was statistically significant.¹⁷ Whether this reflects the cryopreservation process itself, the hormonal environment used to prepare the uterus, or some other factor related to the underlying infertility is still unclear.

What Freezing Does at the Molecular Level

Researchers have been investigating whether the stresses of cryopreservation, including the osmotic shock, rapid temperature changes, and exposure to cryoprotectant chemicals, leave molecular fingerprints on embryos. Reviews of the evidence suggest that vitrification can induce changes in how genes are switched on and off, a layer of biology often called epigenetics.¹⁸

Interestingly, a study comparing gene activity in placentas from frozen transfers, fresh transfers, and natural conceptions found something unexpected. Most of the gene-expression changes seen in frozen-transfer placentas were actually inherited from the IVF process itself, not from the freezing. And some genes that were abnormally active after fresh transfer appeared to revert closer to normal after freezing and thawing. The researchers suggested this partial correction might help explain why fetal growth restriction is less common after frozen transfers.¹⁹ It is a counterintuitive finding and far from settled science, but it pushes back against the assumption that freezing necessarily adds molecular damage.

Fertility Preservation Before Cancer Treatment

Embryo cryopreservation has an important role beyond standard IVF. For people facing cancer treatment, chemotherapy and radiation can severely damage the ovaries or testes, sometimes permanently. Freezing embryos before treatment begins is one of the most established ways to preserve the option of having biological children afterward. Clinical guidelines recommend that fertility preservation be offered systematically to reproductive-age women facing medium- or high-risk chemotherapy regimens.²⁰

A practical challenge in oncofertility is that patients often need to start cancer treatment quickly, which limits the time available for ovarian stimulation and egg retrieval. Fortunately, modern stimulation protocols have been adapted to work within tight windows, sometimes starting at random points in the menstrual cycle rather than waiting for the ideal time. For patients without a partner or who do not wish to create embryos with a sperm donor, freezing unfertilized eggs is an alternative that avoids the need for fertilization before storage.

The Emotional Weight of Stored Embryos

A dimension of embryo cryopreservation that does not get discussed enough is what happens after treatment is over. Patients who complete their families through IVF often find themselves with surplus frozen embryos and no clear plan for them. The decision about what to do with those embryos — continue storing them, donate them to another person or couple, donate them to research, or have them thawed and discarded — is frequently described as one of the hardest parts of the IVF experience.²¹

The difficulty stems partly from how people think about the status of their embryos. Some view them as potential children, others as biological material with sentimental meaning, and many hold both views simultaneously. Qualitative research with IVF patients has found that those who view their embryos as life forms often experience guilt and sorrow when facing disposition choices, particularly when they feel they lack adequate information or acceptable options.²² Practical factors like accumulating storage fees also weigh on the decision, creating pressure to resolve something that many people would prefer to leave open-ended.

Legal frameworks vary enormously. Some countries allow donation to other patients, while others prohibit it. Some permit donation to research; others do not. In Israel, for instance, donating embryos to research is legal but donating them to other infertile people is not, which narrows the options in ways patients may not have anticipated when they started treatment.²³ Many patients cope by simply continuing to pay storage fees year after year, deferring the decision indefinitely. Clinics and counselors increasingly recognize that patients benefit from earlier, more explicit conversations about embryo disposition, ideally before they begin their IVF cycle rather than after their family is complete.